Compare YUM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YUM | HLN |
|---|---|---|
| Founded | 1997 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Restaurants | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6B | 43.7B |
| IPO Year | 1997 | N/A |
| Metric | YUM | HLN |
|---|---|---|
| Price | $152.88 | $10.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 1 |
| Target Price | ★ $165.44 | N/A |
| AVG Volume (30 Days) | 1.8M | ★ 7.5M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.86% | 1.73% |
| EPS Growth | N/A | ★ 41.64 |
| EPS | ★ 5.13 | 0.23 |
| Revenue | $8,061,000,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $9.15 | $1.51 |
| Revenue Next Year | $9.61 | $4.67 |
| P/E Ratio | $29.80 | ★ $22.02 |
| Revenue Growth | ★ 11.60 | N/A |
| 52 Week Low | $125.51 | $8.71 |
| 52 Week High | $163.30 | $11.42 |
| Indicator | YUM | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 65.82 |
| Support Level | $153.07 | $9.71 |
| Resistance Level | $161.06 | $10.36 |
| Average True Range (ATR) | 2.98 | 0.16 |
| MACD | -0.37 | 0.03 |
| Stochastic Oscillator | 35.83 | 98.63 |
As of the end of 2024, Yum Brands generated over $65 billion in systemwide sales from more than 61,000 restaurants across 155 markets, making it the world's second-largest restaurant firm by dollar sales. Its portfolio includes KFC (31,981 stores), Pizza Hut (20,225), Taco Bell (8,757), and Habit Burger (383), with 70% of locations in international markets. As 98% of its portfolio is franchised, Yum's business model is tilted toward recurring franchise royalties and marketing contributions (66% of revenue), with the balance derived from sales at company-owned locations. The company traces its roots to a 1997 spinoff of PepsiCo's restaurant assets.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.